TrialThe Kaohsiung journal of medical sciences2014

Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancer.

Yi-Ping Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.